Objective: To identify potential predictors of Meconium Aspiration Syndrome (MAS) in pregnancies complicated by meconium-stained amniotic fluid (MSAF) & to review the incidence, morbidity and mortality of Meconium Aspiration Syndrome (MAS). Methods: In the period of 2003 to 2006,175 pregnancies with thick meconium-stained AF were delivered; of these, 15 neonates developed MAS and 160 did not. The two groups were compared retrospectively according to maternal findings, pregnancy outcome, and neonatal complications, using univariate analysis (P < 0.05 considered significant) and stepwise multiple logistic regression analysis to identify independent significant factors for prediction of MAS. Results: Incidence of MSAF was 13.97% and that of MAS was 8
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Introduction
Meconium Staining of Amniotic Fluid (MSAF) is a relatively common problem occurring in 8-15% of all deliveries
1
. The most important concern with MSAF is its association with foetal distress and adverse perinatal outcome. The first intestinal discharge from newborns is Meconium, which is a viscous, dark green substance composed of intestinal epithelial cells, lanugo, mucus, and intestinal secretions, such as bile. Intestinal secretions, mucosal cells, and solid elements of swallowed amniotic fluid are the 3 major solid constituents of Meconium. Water is the major liquid constituent, making up 85-95% of Meconium. Intrauterine distress can cause passage into the amniotic fluid. Factors that promote the passage in-utero include placental insufficiency, maternal hypertension, pre-ecclampsia, oligohydramnios, and maternal drug abuse, especially of tobacco and cocaine
2
. Meconium Stained Amniotic Fluid may be aspirated during labour and delivery, causing neonatal respiratory distress. Because Meconium is rarely found in the amniotic fluid prior to 34 weeks' gestation, Meconium Aspiration chiefly affects infants at term and post-term. Ostera found that 78% of MSAF occurred between 38 and 42 weeks of gestation
3
. MAS develop in 5-10 % of the babies born through MSAF
4
. Meconium Aspiration Syndrome (MAS) is a disease with complex pathophysiology & a potential for mortality and considerable morbidity. Despite the recent advances in neonatal care, at least 5% of MAS babies admitted to neonatal intensive care unit (NICU) have been reported to die. Five percent of MAS babies require oxygen in the neonatal period. Infants developed complications including persistent foetal circulation, pneumothorax, and acute renal failure. No reliable data is available as to the incidence of MAS in developing countries including Nepal where sizable numbers of deliveries are conducted at home. There is no uniform standard protocol for management of such babies. So this work has been undertaken to evaluate the management of MSAF babies in the delivery room and its further outcome.
Aim Of Study:
To review the incidence, morbidity and mortality of Meconium Aspiration Syndrome (MAS) and also to identify possible predictors of MAS in newborns with Meconium Stained Amniotic Fluid (MSAF).
Materials and Methods:
The descriptive, quantitative and retrospective analysis of babies born through MSAF at Manipal College of Medical Sciences (MCOMS), Pokhara, Nepal from January 2002 to December 2005 was done in relation to predict different risk factors that increased the morbidity & mortality of MAS. Babies having culture positive septicaemia and any other congenital or cardiac disease were excluded from study. Pvalue less than 0.05 were considered significant.
Results:
Out of total 1252 babies in the study 372 (29.72%) were delivered by caesarean section (LSCS) and those by Normal Vaginal Delivery (NVD) were 880 (70.28%). 175 (13.97%) babies had been born through MSAF. As per Table- III) those that developed MAS had significantly low 1 minute and 5 minute Apgar score than those who did not develop MAS (p < 0.005). MAS babies are associated with higher gestational age (>41.20+1.80weeks) as compared with MSAF (39.50+2.80weeks). Differences in relation to maternal age, birth weight and parity of mother between 2 groups were not statistically significant. Babies with MAS (n=15) showed varying degree of pulmonary parenchymal pathology such as diffuse patchy infiltration, lobar consolidation, atelectasis, airleak syndrome etc, with no direct relation between severity of MAS and degree of radiological lesions. Table- 
Discussion:
With a view to evaluate the morbidity, mortality and possible predictors of MAS in MSAF babies, the study concluded some important facts which need to be observed in managing these cases in developing countries with limited resources.
Meconium-stained amniotic fluid (MSAF) is present in 8-15 % of all deliveries. Our data like other studies shows higher rate of MSAF in higher gestational age. It is interesting to note that all term babies don't pass Meconium in amniotic fluid. The reasons being: i) Presence of thick viscous Meconium cap at the distal end of a GIT. ii) Pronounced peristaltic movements are unusual in foetus and iii) Anal sphincter tone is greater in foetus than neonate.
MSAF is unusual before 36 weeks of gestation (5%). This is postulated to be due to the increasing levels of intestinal hormone motilin with increasing gestational age which brings about faster intestinal movements, defecation and maturation of innervations of GIT associated with vagal stimulation 7 . Levels of this hormone could be taken as a useful predictor of pre and or intrapartum asphyxia in the sense that more motilin could effect more Meconium passage into amniotic fluid giving rise to thick or pea-soup appearing MSAF and resultant out come. MSAF in itself is a sign of foetal hypoxia and acidosis. Burgess AM, Hutchins GMin 1996 reviewed 123 autopsies with history suggestive of MAS and found high incidence of pulmonary infiltration, umbilical cord constriction, and inflammation of both umbilical cord and chorionic plate 8 . They speculated that Meconium itself may be potential cause of foetal distress.
MAS is defined as a condition where after the aspiration the neonate develops respiratory distress, staining of nails, cord skin and other symptoms that cannot be explained 8 . Our centre has employed a selective approach to the airway management of infants with Meconium-stained fluid. Infants with clear amniotic fluid were managed without tracheal suctioning. The obstetrician routinely suctioned the oral and nasopharyngeal airway of any foetus exposed to Meconiumstained fluid before delivery of the shoulder and thorax. After delivery, infants with thin Meconium stained fluid were managed similar to infants with clear amniotic fluid. Postdelivery neonatal management of infants born through thick Meconium stained fluid were based on the infant's condition immediately after birth. Infants with good tone, respiratory effort, and cry did not receive routine laryngoscopy or tracheal suctioning. Depressed infants had laryngoscopy performed
9
. Suction was applied through either an endotracheal tube or a 10-F suction catheter with wall suction of at least 100 mmHg. Use of assisted ventilation via endotracheal tube was applied as needed following the guidelines of the American Academy of Pediatrics and American Heart Association or Neonatal Resuscitation Program (NRP) 10 . Aspiration of Meconium causes considerable perinatal morbidity and mortality. We observed in our study that 13.97% of total live births were associated with MSAF and 8.5% of MSAF babies developed MAS. These findings are consistent with other studies
Newborns with thick MSAF were more likely to develop MAS if they had fetal distress and Meconium was not sucked from the trachea at birth. Passage of thick Meconium was significantly associated with severe asphyxia and carried a bad prognosis with increased risk of development of Meconium aspiration syndrome, hypoxic ischaemic encephalopathy, seizures and pulmonary air leak syndrome. Our study shows that all the babies with thick MSAF had MAS and all these babies had direct tracheal suction in the delivery room. 80% of our intubated newborns showed tracheal Meconium and all of them developed MAS. Liu WF, Harrington T, made similar observations
11
.
Another observation from our study is that the group that developed MAS had a significantly (p< 0.005) higher incidence of Lower Section Cesarean Section (LSCS) than the group that did not develop MAS, which is 66.6% and 32.50%, respectively. These results are again consistent with the findings from other studies 12 . Some studies have shown that babies with MSAF have lower 1-min and 5-min Apgar scores than the babies that do not have MSAF 13 . In our study, neonates who developed MAS and had a 1-min and 5-min Apgar scores of 6 or less had significantly lower scores (p<0.005) than those who had no MAS with MSAF. MAS babies are associated with higher gestational age (>40.27+1.81weeks) as compared with MSAF (39.50+2.89weeks) which was consistent with study done by Bhasker S.H
5
. There is a very interesting finding in relation to indication of LSCS and neonatal outcome. Nine cases out of ten LSCS babies having foetal distress with or without nonprogression of labour had indication of for LSCS. This is in tune with the study done by Bhaskar 
Conclusion:
The neonatal morbidity was significantly more frequent in relation to thick Meconium and also when perinatal asphyxia was associated with MSAF. Thick Meconium is implicated as a risk factor influencing the well being during the intrapartum and postpartum periods. These can be inferred from the study with review of literatures showing that: a) MAS are associated with higher incidence of LSCS. b) MAS had lower 1 minute and 5 minute Apgar score. c) MAS are associated with higher gestational weeks. d) 40% mothers were associated with PROM and prolonged labour. Identification of post-term pregnancy and prenatal asphyxia are the best preventions for MAS. Early identification of antenatal and perinatal risk factors, higher cesarean delivery rates, and decrease in the proportion of post-dated births, appropriate delivery room management and diagnosis of post natal complication with its timely management can prevent morbidity and mortality of MAS.
